The global market for 503B Compounding Pharmacies is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC 503B Compounding Pharmacies market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States 503B Compounding Pharmacies market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe 503B Compounding Pharmacies market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China 503B Compounding Pharmacies market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key 503B Compounding Pharmacies players cover Central Admixture Pharmacy Services, Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy and ASP Cares, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global 503B Compounding Pharmacies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global 503B Compounding Pharmacies market, with both quantitative and qualitative data, to help readers understand how the 503B Compounding Pharmacies market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the 503B Compounding Pharmacies market and forecasts the market size by Type (Acetaminophen, Phenylephrine and Midazolam), by Application (On-line and Offline.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Acetaminophen
Phenylephrine
Midazolam
Esmolol
Vancomycin
Epinephrine
Adenocaine
Fentanyl/ Bupivacaine
Morphine
Other
Segmentation by application
On-line
Offline
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Central Admixture Pharmacy Services
Nephron Pharmaceuticals Corporation
QuVa Pharma
Olympia Pharmacy
ASP Cares
Fagron Compounding Pharmacies
Athenex, Inc.
Avella Specialty Pharmacy
Atlas Pharmaceuticals
Empower Pharmacy
Carie Boyd'S Prescription Shop
Edge Pharma, Imprimis NJOF
IntegraDose Compounding services
Wells Pharma of Houston, LLC
US Compounding Inc.
SCA Pharma
Chapter Introduction
Chapter 1: Scope of 503B Compounding Pharmacies, Research Methodology, etc.
Chapter 2: Executive Summary, global 503B Compounding Pharmacies market size and CAGR, 503B Compounding Pharmacies market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: 503B Compounding Pharmacies revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global 503B Compounding Pharmacies revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global 503B Compounding Pharmacies market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Central Admixture Pharmacy Services, Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy, ASP Cares, Fagron Compounding Pharmacies, Athenex, Inc., Avella Specialty Pharmacy and Atlas Pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 503B Compounding Pharmacies Market Size 2017-2028
2.1.2 503B Compounding Pharmacies Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 503B Compounding Pharmacies Segment by Type
2.2.1 Acetaminophen
2.2.2 Phenylephrine
2.2.3 Midazolam
2.2.4 Esmolol
2.2.5 Vancomycin
2.2.6 Epinephrine
2.2.7 Adenocaine
2.2.8 Fentanyl/ Bupivacaine
2.2.9 Morphine
2.2.10 Other
2.3 503B Compounding Pharmacies Market Size by Type
2.3.1 503B Compounding Pharmacies Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global 503B Compounding Pharmacies Market Size Market Share by Type (2017-2022)
2.4 503B Compounding Pharmacies Segment by Application
2.4.1 On-line
2.4.2 Offline
2.5 503B Compounding Pharmacies Market Size by Application
2.5.1 503B Compounding Pharmacies Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global 503B Compounding Pharmacies Market Size Market Share by Application (2017-2022)
3 503B Compounding Pharmacies Market Size by Player
3.1 503B Compounding Pharmacies Market Size Market Share by Players
3.1.1 Global 503B Compounding Pharmacies Revenue by Players (2020-2022)
3.1.2 Global 503B Compounding Pharmacies Revenue Market Share by Players (2020-2022)
3.2 Global 503B Compounding Pharmacies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 503B Compounding Pharmacies by Regions
4.1 503B Compounding Pharmacies Market Size by Regions (2017-2022)
4.2 Americas 503B Compounding Pharmacies Market Size Growth (2017-2022)
4.3 APAC 503B Compounding Pharmacies Market Size Growth (2017-2022)
4.4 Europe 503B Compounding Pharmacies Market Size Growth (2017-2022)
4.5 Middle East & Africa 503B Compounding Pharmacies Market Size Growth (2017-2022)
5 Americas
5.1 Americas 503B Compounding Pharmacies Market Size by Country (2017-2022)
5.2 Americas 503B Compounding Pharmacies Market Size by Type (2017-2022)
5.3 Americas 503B Compounding Pharmacies Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 503B Compounding Pharmacies Market Size by Region (2017-2022)
6.2 APAC 503B Compounding Pharmacies Market Size by Type (2017-2022)
6.3 APAC 503B Compounding Pharmacies Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe 503B Compounding Pharmacies by Country (2017-2022)
7.2 Europe 503B Compounding Pharmacies Market Size by Type (2017-2022)
7.3 Europe 503B Compounding Pharmacies Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 503B Compounding Pharmacies by Region (2017-2022)
8.2 Middle East & Africa 503B Compounding Pharmacies Market Size by Type (2017-2022)
8.3 Middle East & Africa 503B Compounding Pharmacies Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global 503B Compounding Pharmacies Market Forecast
10.1 Global 503B Compounding Pharmacies Forecast by Regions (2023-2028)
10.1.1 Global 503B Compounding Pharmacies Forecast by Regions (2023-2028)
10.1.2 Americas 503B Compounding Pharmacies Forecast
10.1.3 APAC 503B Compounding Pharmacies Forecast
10.1.4 Europe 503B Compounding Pharmacies Forecast
10.1.5 Middle East & Africa 503B Compounding Pharmacies Forecast
10.2 Americas 503B Compounding Pharmacies Forecast by Country (2023-2028)
10.2.1 United States 503B Compounding Pharmacies Market Forecast
10.2.2 Canada 503B Compounding Pharmacies Market Forecast
10.2.3 Mexico 503B Compounding Pharmacies Market Forecast
10.2.4 Brazil 503B Compounding Pharmacies Market Forecast
10.3 APAC 503B Compounding Pharmacies Forecast by Region (2023-2028)
10.3.1 China 503B Compounding Pharmacies Market Forecast
10.3.2 Japan 503B Compounding Pharmacies Market Forecast
10.3.3 Korea 503B Compounding Pharmacies Market Forecast
10.3.4 Southeast Asia 503B Compounding Pharmacies Market Forecast
10.3.5 India 503B Compounding Pharmacies Market Forecast
10.3.6 Australia 503B Compounding Pharmacies Market Forecast
10.4 Europe 503B Compounding Pharmacies Forecast by Country (2023-2028)
10.4.1 Germany 503B Compounding Pharmacies Market Forecast
10.4.2 France 503B Compounding Pharmacies Market Forecast
10.4.3 UK 503B Compounding Pharmacies Market Forecast
10.4.4 Italy 503B Compounding Pharmacies Market Forecast
10.4.5 Russia 503B Compounding Pharmacies Market Forecast
10.5 Middle East & Africa 503B Compounding Pharmacies Forecast by Region (2023-2028)
10.5.1 Egypt 503B Compounding Pharmacies Market Forecast
10.5.2 South Africa 503B Compounding Pharmacies Market Forecast
10.5.3 Israel 503B Compounding Pharmacies Market Forecast
10.5.4 Turkey 503B Compounding Pharmacies Market Forecast
10.5.5 GCC Countries 503B Compounding Pharmacies Market Forecast
10.6 Global 503B Compounding Pharmacies Forecast by Type (2023-2028)
10.7 Global 503B Compounding Pharmacies Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Central Admixture Pharmacy Services
11.1.1 Central Admixture Pharmacy Services Company Information
11.1.2 Central Admixture Pharmacy Services 503B Compounding Pharmacies Product Offered
11.1.3 Central Admixture Pharmacy Services 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Central Admixture Pharmacy Services Main Business Overview
11.1.5 Central Admixture Pharmacy Services Latest Developments
11.2 Nephron Pharmaceuticals Corporation
11.2.1 Nephron Pharmaceuticals Corporation Company Information
11.2.2 Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Product Offered
11.2.3 Nephron Pharmaceuticals Corporation 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Nephron Pharmaceuticals Corporation Main Business Overview
11.2.5 Nephron Pharmaceuticals Corporation Latest Developments
11.3 QuVa Pharma
11.3.1 QuVa Pharma Company Information
11.3.2 QuVa Pharma 503B Compounding Pharmacies Product Offered
11.3.3 QuVa Pharma 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 QuVa Pharma Main Business Overview
11.3.5 QuVa Pharma Latest Developments
11.4 Olympia Pharmacy
11.4.1 Olympia Pharmacy Company Information
11.4.2 Olympia Pharmacy 503B Compounding Pharmacies Product Offered
11.4.3 Olympia Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Olympia Pharmacy Main Business Overview
11.4.5 Olympia Pharmacy Latest Developments
11.5 ASP Cares
11.5.1 ASP Cares Company Information
11.5.2 ASP Cares 503B Compounding Pharmacies Product Offered
11.5.3 ASP Cares 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 ASP Cares Main Business Overview
11.5.5 ASP Cares Latest Developments
11.6 Fagron Compounding Pharmacies
11.6.1 Fagron Compounding Pharmacies Company Information
11.6.2 Fagron Compounding Pharmacies 503B Compounding Pharmacies Product Offered
11.6.3 Fagron Compounding Pharmacies 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Fagron Compounding Pharmacies Main Business Overview
11.6.5 Fagron Compounding Pharmacies Latest Developments
11.7 Athenex, Inc.
11.7.1 Athenex, Inc. Company Information
11.7.2 Athenex, Inc. 503B Compounding Pharmacies Product Offered
11.7.3 Athenex, Inc. 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Athenex, Inc. Main Business Overview
11.7.5 Athenex, Inc. Latest Developments
11.8 Avella Specialty Pharmacy
11.8.1 Avella Specialty Pharmacy Company Information
11.8.2 Avella Specialty Pharmacy 503B Compounding Pharmacies Product Offered
11.8.3 Avella Specialty Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Avella Specialty Pharmacy Main Business Overview
11.8.5 Avella Specialty Pharmacy Latest Developments
11.9 Atlas Pharmaceuticals
11.9.1 Atlas Pharmaceuticals Company Information
11.9.2 Atlas Pharmaceuticals 503B Compounding Pharmacies Product Offered
11.9.3 Atlas Pharmaceuticals 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Atlas Pharmaceuticals Main Business Overview
11.9.5 Atlas Pharmaceuticals Latest Developments
11.10 Empower Pharmacy
11.10.1 Empower Pharmacy Company Information
11.10.2 Empower Pharmacy 503B Compounding Pharmacies Product Offered
11.10.3 Empower Pharmacy 503B Compounding Pharmacies Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Empower Pharmacy Main Business Overview
11.10.5 Empower Pharmacy Latest Developments
11.11 Carie Boyd